Refine your search with filters

All-Materials All
Congress-AbstractsCongress Abstracts
Tools-SkillsTools & Skills
PublicationsPublications
Congress-SlidesCongress Presentations
Videos-PodcastsVideos & Podcasts

Quicksearch

P317: Postoperative complications, outcome, quality of life and self-image after ileal pouch-anal anastomosis in patients operated due to acute, severe or chronic, therapy refractory ulcerative colitisECCO '17 Barcelona
Year: 2017
Authors:

Balint A.*1, Czinderi V.1, Szucs M.2, Rutka M.1, Farkas K.1, Szepes Z.1, Nagy F.1, Fábián A.1, Bor R.1, Milassin A.1, Lázár G.3, Molnár T.1

1University of Szeged, First Department of Medicine, Szeged, Hungary 2University of Szeged, Department of Medical Physics and Informatics, Szeged, Hungary 3University of Szeged, Department of Surgery, Szeged, Hungary

P318: Accuracy of magnetic resonance enterography for extraluminal complications of Crohn's diseaseECCO '17 Barcelona
Year: 2017
Authors:

Pecoraro G.M.*1, Orlando A.2, TesÈ L.3, Solina G.4, Di Mitri R.5, Mocciaro F.5, Renna S.2, Cottone M.2

1ARNAS Civico-Di Cristina-Benfratelli Hospital, Department of Gastroenterology, Palermo, Italy 2Riuniti Villa Sofia - Cervello Hospital, Department of Internal Medicine, Palermo, Italy 3Riuniti Villa Sofia - Cervello Hospital, Radiology, Palermo, Italy 4Riuniti Villa Sofia - Cervello Hospital, surgical department, Palermo, Italy 5ARNAS Civico-Di Cristina-Benfratelli Hospital, Department of Gastroenterology and Endoscopy, Palermo, Italy

P319: Accurate cut-offs for predicting endoscopic activity and mucosal healing in Crohn's disease with fecal calprotectinECCO '17 Barcelona
Year: 2017
Authors:

Vázquez-Morόn J.M.*1, Benítez-Rodríguez B.2, Pallarés-Manrique H.1, Machancoses F.H.3, Robles Rodríguez J.L.4, Ramos-Lora M.1, Ruíz-Frutos C.5

1Hospital General Juan Ramόn Jiménez, Gastroenterology Unit, Huelva, Spain 2Hospital Universitario Virgen Macarena, Gastroenterology Unit, Sevilla, Spain 3Hospital General Juan Ramόn Jiménez, Methodology Unit, Huelva, Spain 4Hospital General Juan Ramόn Jiménez, Clinical Laboratory Unit, Huelva, Spain 5Universidad de Huelva, Departament of Environmental Biology and Public Health, Huelva, Spain

P320: Utility of a semi-quantitative rapid test in diagnosis of ulcerative colitisECCO '17 Barcelona
Year: 2017
Authors:

Dranga M.*1, Mihai C.1, Gavrilescu O.1, Ungureanu I.1, Cucuteanu B.2, Cijevschi-Prelipcean C.1

1University of Medicine and Pharmacy “Grigore T. Popa”, Iasi, Romania 2Institute of Gastroenterology and Hepatology, Iasi, Romania

P321: Activity graph patterns recorded using a mobile monitoring system are associated with clinical outcomes of patients with Crohn's diseaseECCO '17 Barcelona
Year: 2017
Authors:

Kim E.S.*1, Jang B.I.2, Kim K.O.2, Kim E.Y.3, Lee H.S.1, Kwak S.G.4, Lee E.Y.1, Lee Y.J.5 Crohn's and Colitis Association in Daegu-Gyeongbuk (CCAiD)

1Kyungpook National University School of Medicine, Internal Medicine, Daegu, South Korea 2Yeungnam University College of Medicine, Department of Internal Medicine, Daegu, South Korea 3Catholic University of Daegu, Department of Internal Medicine, Daegu, South Korea 4Catholic University of Daegu School of Medicine, Medical Statistics, Daegu, South Korea 5Keimyung University School Of Medicine, Department of Internal Medicine, Daegu, South Korea

P322: A change in ΔMCV predicts mucosal healing in patients with Crohn's disease under combination therapyECCO '17 Barcelona
Year: 2017
Authors:

Bernardo S., Fernandes S., Correia L., Velosa J.

Hospital Santa Maria, CHLN, Department of Gastroenterology and Hepatology, Lisbon, Portugal

P323: Fatty liver assessment in inflammatory bowel disease patients using controlled attenuation parameterECCO '17 Barcelona
Year: 2017
Authors:

Balaban D.V.*1, Popp A.2,3,4, Robu G.5, Bucurica S.2,5, Costache R.S.2,5, Nuta P.5, Ionita Radu F.5,6, Jinga M.2,5

1“Carol Davila” University of Medicine and Pharmacy, Internal Medicine and Gastroenterology, Bucharest, Romania 2“Carol Davila” University of Medicine and Pharmacy, Bucharest, Romania 3“Alessandrescu Rusescu” National Institute for Mother and Child Health, Bucharest, Romania 4Tampere Center for Child Health Research, University of Tampere and Tampere University Hospital, Tampere, Finland 5“Dr. Carol Davila” Central Military Emergency University Hospital, Bucharest, Romania 6Titu Maiorescu University- Faculty of Medicine, Bucharest, Romania

P324: Evaluation of ability to predict mucosal healing by quantitative fecal immunochemical test in ulcerative colitisECCO '17 Barcelona
Year: 2017
Authors:

Kim H.W.*1, Song G.A.2, Kang D.H.3, Choi C.W.3, Ryu D.G.3

1Pusan National University Yangsan Hospital, Internal medicine, Yangsan, South Korea 2Pusan National University Hospital, Pusan, South Korea 3Pusan National University Yangsan Hospital, Yangsan, South Korea

P325: Combination therapy with adalimumab and immunomodulators decreases incidence of intestinal resection in Crohn's disease patients previously treated with infliximab: a large, multicentre cohort studyECCO '17 Barcelona
Year: 2017
Authors:

Tanaka H.*1, Kamata N.2, Yamada A.3, Fujii T.4, Endo K.5, Yoshino T.6,7, Sugaya T.8, Kawaguchi T.9, Bamba S.10, Ishii M.11, Shinzaki S.12, Toya Y.13, Yanai Y.14, Yokoyama Y.15, Umeno J.16, Okada T.17, Kobayashi T.18, Nojima M.19, Hibi T.18 the ADJUST Study Group

1Sapporo Kosei General Hospital, IBD Center, Sapporo, Japan 2Osaka City University Graduate School of Medicine, Department of Gastroenterology, Osaka, Japan 3Toho University Sakura Medical Center, Department of Internal Medicine, Sakura, Japan 4Tokyo Medical and Dental University, Department of Gastroenterology and Hepatology, Tokyo, Japan 5Tohoku University Graduate School of Medicine, Division of Gastroenterology, Sendai, Japan 6Kitano Hospital, Tazuke Kofukai Medical Research Institute, IBD Center, Osaka, Japan 7Kyoto University, Graduate School of Medicine, Department of Gastroenterology and Hepatology, Kyoto, Japan 8Dokkyo Medical University, Department of Gastroenterology, Mibu, Japan 9Tokyo Yamate Medical Center, Department of Internal Medicine, Division of IBD, Tokyo, Japan 10Shiga University of Medical Science, Division of Gastroenterology, Otsu, Japan 11Kawasaki Medical School, Department of Internal Medicine, Division of Gastroenterology, Kurashiki, Japan 12Osaka University Graduate School of Medicine, Department of Gastroenterology and Hepatology, Suita, Japan 13Iwate Medical University, School of Medicine, Division of Gastroenterology, Iwate, Japan 14Oita Red Cross Hospital, Department of Gastroenterology, Oita, Japan 15Hyogo College of Medicine, Division of Internal Medicine, Department of Inflammatory Bowel Disease, Nishinomiya, Japan 16Kyushu University, Department of Medicine and Clinical Science, Graduate School of Medical Sciences, Fukuoka, Japan 17Osaka Medical College, Second Department of Internal Medicine, Takatsuki, Japan 18Kitasato University Kitasato Institute Hospital, Center for Advanced IBD Research and Treatment, Tokyo, Japan 19The University of Tokyo, The Institute of Medical Science, Center for Translational Research, Tokyo, Japan

P326: Efficacy of vedolizumab on patient-reported outcomes in ulcerative colitis patients: results from a prospective German observational studyECCO '17 Barcelona
Year: 2017
Authors:

Schmidt C.*1, Langbein C.1, Atreya R.2, Bruns T.1, Dignass A.3, Ende K.4, Hampe J.5, Hartmann F.3, Neurath M.F.2, Maul J.6,7, Preiss J.C.7, Schmelz R.5, Siegmund B.7, Schulze H.3, Teich N.8, van Arnim U.9, Baumgart D.C.10, Stallmach A.1

1Jena University Hospital, Department of Gastroenterology, Jena, Germany 2Friedrich-Alexander University Erlangen-Nürnberg, Medical Clinic 1, Erlangen, Germany 3Agaplesion Markus Hospital, Department of Medicine I, Frankfurt/Main, Germany 4HELIOS Hospital Erfurt, Department of Internal Medicine, Erfurt, Germany 5University Hospital Dresden, Technical University Dresden, Medical Department 1, Dresden, Germany 6Gastroenterologie am Bayerischen Platz, Berlin, Germany 7Charité Medical School, Department of Medicine (Gastroenterology, Infectious Diseases, Rheumatology), Berlin, Germany 8Group Practice for Digestive and Metabolic Diseases, Leipzig, Germany 9Otto-von-Guericke-University Magdeburg, 9Department of Gastroenterology, Hepatology and Infectious Diseases, Magdeburg, Germany 10Charité Medical School, Humboldt-University of Berlin, 10Department of Gastroenterology and Hepatology, Berlin, Germany

P327: Evolution after a “de-intensification” strategy with anti-TNF therapy in patients with inflammatory bowel disease in clinical remission: multicenter studyECCO '17 Barcelona
Year: 2017
Authors:

Benítez J.M.*1, Barreiro-de Acosta M.2, Chaparro M.3, Vázquez J.M.4, Iglesias-Flores E.1, Tosca J.5, García-Planella E.6, García-Lόpez S.7, Taxonera C.8, Muñoz-Villafranca M.9, Pajares R.10, Barrio J.11, Arias L.12, Nantes O.13, Fernández-Salazar L.14, Hervías D.15, Martín-Arranz M.16, Mesonero F.17, Moraleja-Yudejo I.18, Pineda J.19, Argüelles-Arias F.20, Huguet J.21, Hernández-Martínez A.22, Pérez-Calle J.23, Leo E.24, Merino O.25, Van Domselaar M.26, Gutiérrez A.27, Lorente R.28, Castro M.29, Algaba A.30, Castro E.31, Robles-Alonso V.32, Ceballos D.33, Gόmez-García R.34, Domínguez J.35, Fernández E.36, Vega-Lόpez A.37, Trapero A.38, Talavera A.39, Royo V.40, Gisbert J.P.3, García-Sánchez V.1

1Hospital Universitario Reina Sofía, Gastroenterology, Cόrdoba, Spain 2Hospital Clínico Universitario de Santiago de Compostela, Santiago de Compostela, Spain 3Hospital Universitario de La Princesa, Madrid, Spain 4Hospital Juan Ramόn Jiménez, Huelva, Spain 5Hospital Clínico Valencia, Valencia, Spain 6Hospital de la Santa Creu I Sant Pau, Barcelona, Spain 7Hospital Universitario Miguel Servet, Zaragoza, Spain 8Hospital Universitario Clínico San Carlos, Madrid, Spain 9Hospital de Basurto, Bilbao, Spain 10Hospital Universitario Infanta Sofía, Madrid, Spain 11Hospital Universitario Río Hortega, Valladolid, Spain 12Hospital Universitario de Burgos, Burgos, Spain 13Complejo Hospitalario de Navarra, Pamplona, Spain 14Hospital Clínico Universitario de Valladolid, Valladolid, Spain 15Hospital Virgen de Altagracia, Ciudad Real, Spain 16Hospital Universitario La Paz, Madrid, Spain 17Hospital Universitario Ramόn y Cajal, Madrid, Spain 18Hospital de Galdakao-Usansolo, Galdakao, Spain 19Complejo Hospitalario Universitario de Vigo, Vigo, Spain 20Hospital Universitario Virgen Macarena, Sevilla, Spain 21Consorcio Hospital General Universitario de Valencia, Valencia, Spain 22Hospital Torrecárdenas, Almería, Spain 23Hospital Universitario Fundaciόn de Alcorcόn, Madrid, Spain 24Hospital Universitario Virgen del Rocío, Sevilla, Spain 25Hospital Universitario Cruces, Barakaldo, Spain 26Hospital de Torrejόn de Ardoz, Madrid, Spain 27Hospital General Universitario de Alicante, Alicante, Spain 28Hospital General de Ciudad Real, Ciudad Real, Spain 29Hospital Universitario de Valme, Sevilla, Spain 30Hospital Universitario de Fuenlabrada, Madrid, Spain 31Hospital Lucus Augusti, Lugo, Spain 32Hospital Universitario Vall d'Hebron, Barcelona, Spain 33Hospital Universitario Dr. Negrín, Las Palmas, Spain 34Hospital Universitario Virgen de las Nieves, Granada, Spain 35Hospital Alto Guadalquivir, Andújar, Spain 36Hospital Provincial de Pontevedra, Pontevedra, Spain 37Hospital de Viladecans, Viladecans, Spain 38H. de Jaén, Jaén, Spain 39H. Infanta Elena, Huelva, Spain 40H. Son Espases, Palma Mallorca, Spain

P328: Patient and physician perspectives on managing iron deficiency with or without anaemia in inflammatory bowel disease: findings from a European online surveyECCO '17 Barcelona
Year: 2017
Authors:

Danese S.1, Gisbert J.P.2, Lobo A.J.3, Dignass A.4, Peyrin-Biroulet L.5, Kokot M.*6, Avedano L.7

1Humanitas University, Department of Biomedical Sciences, Milan, Italy 2Hospital Universitario de la Princesa, IIS-IP and CIBEREHD, Gastroenterology Unit, Madrid, Spain 3Royal Hallamshire Hospital and University of Sheffield, Sheffield, United Kingdom 4Agaplesion Markus Hospital, Goethe University, Department of Medicine I, Frankfurt, Germany 5University Hospital of Nancy, Lorraine University, Department of Hepato-Gastroenterology and Inserm U954, Vandoeuvre-lès-Nancy, France 6Vifor Pharma Ltd., Glattbrugg, Switzerland 7European Federation of Crohn's and Ulcerative Colitis Associations, Brussels, Belgium

P329: Effect of adalimumab dose escalation on clinical, health-related quality of life, treatment satisfaction and work productivity outcomes among patients with ulcerative colitis in a clinical practice setting: results from INSPIRADAECCO '17 Barcelona
Year: 2017
Authors:

Travis S.*1, Feagan B.2, Peyrin-Biroulet L.3, Panaccione R.4, Danese S.5, Lazar A.6, Robinson A.7, Thakkar R.7, Pappalardo B.7, Petersson J.7, Bereswill M.6, Chen N.7, Skup M.7

1Oxford University Hospitals, Oxford, United Kingdom 2Robarts Research Institute, London, Canada 3University Hospital of Nancy, Les Nancy, France 4University of Calgary, Calgary, Canada 5Istituto Clinico Humanitas, Milan, Italy 6AbbVie Deutschland GmbH & Co. KG, Ludwigshafen, Germany 7AbbVie Inc., North Chicago, United States

P330: Discontinuation of corticosteroids among ulcerative colitis patients treated with vedolizumab in the United StatesECCO '17 Barcelona
Year: 2017
Authors:

Patel H.*1, Chastek B.2, Null K.D.3, Demuth D.4

1Immensity Consulting, Inc, Chicago, United States 2Optum, Eden Prairie, United States 3Takeda Pharmaceuticals U.S.A., Inc., Health Economics and Outcomes Research, Deerfield, United States 4Takeda Development Center Europe Ltd, Evidence and Value Generation, London, United Kingdom

P331: Final results on efficacy and safety of biosimilar infliximab after one-year: results from a prospective nationwide cohortECCO '17 Barcelona
Year: 2017
Authors:

Gecse K.B.*1, Vegh Z.1, Kurti Z.1, Rutka M.2, Farkas K.2, Golovics P.A.1, Lovasz B.D.1, Gonczi L.1, Banai J.3, Bene L.4, Gasztonyi B.5, Kristof T.6, Lakatos L.7, Miheller P.8, Nagy F.2, Palatka K.9, Papp M.9, Patai A.10, Salamon A.11, Szamosi T.3, Szepes Z.2, Toth G.T.12, Vincze A.13, Molnar T.2, Lakatos P.L.1

1Semmelweis University, First Department of Medicine, Budapest, Hungary 2University of Szeged, First Department of Internal Medicine, Szeged, Hungary 3Military Hospital – State Health Centre, Gastroenterology, Budapest, Hungary 4Peterfy Hospital, 1st Department of Medicine, Budapest, Hungary 5Zala County Hospital, 2nd Department of Medicine, Zalaegerszeg, Hungary 6B-A-Z County and University Teaching Hospital, 2nd Department of Medicine, Miskolc, Hungary 7Csolnoky Ferenc Regional Hospital, Department of Internal Medicine, Veszprem, Hungary 8Semmelweis University, Second Departement of Internal Medicine, Budapest, Hungary 9University of Debrecen, Department of Gastroenterology, Debrecen, Hungary 10Markusovszky Hospital, Department of Medicine and Gastroenterology, Szombathely, Hungary 11Tolna County Teaching Hospital, Department of Gastroenterology, Szekszard, Hungary 12Janos Hospital, Department of Gastroenterology, Budapest, Hungary 13University of Pécs, 1st Department of Medicine, Pecs, Hungary

P332: Treat to target in Crohn's disease: ultrasonographic response is associated with better outcomesECCO '17 Barcelona
Year: 2017
Authors:

Zorzi F., Lolli E., Onali S., Petruzziello C., Fantini M.C., Biancone L., Monteleone G., Calabrese E.

Gastroenterology Unit, Department of Systems Medicine, University of Rome “Tor Vergata”, Rome, Italy

P333: Changing patterns of biological therapy use with the introduction of biosimilars in inflammatory bowel diseaseECCO '17 Barcelona
Year: 2017
Authors:

Mortier K.1, Arnott I.*2, Russell R.K.3 UK Inflammatory Bowel Disease (IBD) Audit Steering Group

1Royal College of Physicians, London, United Kingdom 2NHS Lothian - Western General Hospital, Gastrointestinal Unit, Edinburgh, United Kingdom 3Glasgow Royal Hospital for Sick Children, Department of Pediatric Gastroenterology, Glasgow, United Kingdom

P334: Medication adherence in diverse inner city pediatric patients with inflammatory bowel disease and comparison to physician perception of adherenceECCO '17 Barcelona
Year: 2017
Authors:

Ferreira J., Thomas S., Tomer G.

The Children's Hospital at Montefiore/ The University Hospital for Albert Einstein College of Medicine, Pediatric Gastroenterology and Nutrition, Bronx, United States

P335: Prevalence and risk factors for non alcoholic fatty liver disease in inflammatory bowel diseaseECCO '17 Barcelona
Year: 2017
Authors:

Iannone A.*1, Losurdo G.2, Shahini E.1, Albano F.1, La Fortezza R.F.1, Rizzi S.F.1, Contaldo A.1, Barone M.1, Ierardi E.1, Principi M.1, Di Leo A.1

1University of Bari, DETO, Bari, Italy 2University of Bari, Department of Emergency and Organ Transplantation, Bari, Italy

P336: Safety of anti-TNF treatment in older IBD patients: a systematic review and meta-analysisECCO '17 Barcelona
Year: 2017
Authors:

Waars S.1, Dekkers N.1, van der Meulen A.1, Stijnen T.2, Maljaars J.*1

1LUMC, Gastroenterology-Hepatology, Leiden, Netherlands 2LUMC, Department of Medical statistics, Leiden, Netherlands